These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2921690)

  • 1. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.
    Kearns GL; Jacobs RF; Thomas BR; Darville TL; Trang JM
    J Pediatr; 1989 Mar; 114(3):461-7. PubMed ID: 2921690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn.
    Aujard Y; Brion F; Jacqz-Aigrain E; Kasse MC; Chretien P; Criqui C; Mathieu H
    Diagn Microbiol Infect Dis; 1989; 12(1):87-91. PubMed ID: 2653716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young.
    Kearns GL; Young RA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):97-104. PubMed ID: 7587057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.
    Beyssac E; Cardot JM; Colnet G; Sirot J; Aiache JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):91-102. PubMed ID: 3691581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.
    Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
    Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.
    Vallée F; LeBel M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2057-64. PubMed ID: 1759827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cefotaxime/desacetylcefotaxime with two aminoglycosides against gram-negative pathogens: an example of interactive synergy.
    Jenkins SG
    Diagn Microbiol Infect Dis; 1989; 12(1):51-5. PubMed ID: 2714073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
    Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(1):81-5. PubMed ID: 2714075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
    Jacobs RF; Kearns GL
    Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of cefotaxime, desacetylcefotaxime, and the combination of the two.
    Friis H
    Diagn Microbiol Infect Dis; 1989; 12(1):67-72. PubMed ID: 2714074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
    Aldridge KE
    Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cefotaxime alone and in combination with desacetylcefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal beta-lactamase.
    Stratton CW; Kernodle DS; Eades SC; Weeks LS
    Diagn Microbiol Infect Dis; 1989; 12(1):57-65. PubMed ID: 2785444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefotaxime in the postpartum patient.
    Gonik B; Cotton DB; Feldman S; Cleary TG; Pickering LK
    Am J Perinatol; 1985 Apr; 2(2):114-7. PubMed ID: 4096751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.